Selective PPARγ modulators with improved pharmacological profiles
- 1 May 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (10) , 2437-2440
- https://doi.org/10.1016/j.bmcl.2005.03.092
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Benzoyl 2-methyl indoles as selective PPARγ modulatorsPublished by Elsevier ,2004
- Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor-γ ActivityCirculation, 2004
- SUBSTITUENT EFFECT ON THE REDUCTIVE N-DEARYLATION OF 3-(INDOL-1-YL)-1,2-BENZISOXAZOLES BY RAT LIVER MICROSOMESDrug Metabolism and Disposition, 2003
- The Mechanisms of Action of PPARsAnnual Review of Medicine, 2002
- A Unique PPARγ Ligand with Potent Insulin-Sensitizing yet Weak Adipogenic ActivityMolecular Cell, 2001
- PPARγ and the Treatment of Insulin ResistanceTrends in Endocrinology & Metabolism, 2000
- L-764406 Is a Partial Agonist of Human Peroxisome Proliferator-activated Receptor γPublished by Elsevier ,1999
- RosiglitazoneDrugs, 1999
- TroglitazoneDrugs, 1999
- Über 3‐Chlor‐1.2‐benzisoxazoleEuropean Journal of Inorganic Chemistry, 1967